'Reference pricing' diaporamas de présentation

The Politics and Economics of International Energy (Spring 2009- E657)

The Politics and Economics of International Energy (Spring 2009- E657). Lecture 4 The functioning of the international oil market Prof. Giacomo Luciani. Outline. Price formation: past and current regimes Prices, Supply and Demand The Market for Brent Details on the Futures Market

1.07k views • 96 slides

LECTURE 8 modern organizational techniques to improve the profitability of pharmacies

LECTURE 8 modern organizational techniques to improve the profitability of pharmacies. Plan 1. Use merchandising 2. Product and pricing 3. System of discounts 4. Working with MPI and insurance companies ( PILOT PROJECT) 5. Advising doctors and cosmetologists 6. Risk Sharing

536 views • 43 slides

Approaches to Pharmaceutical Regulation in Europe and the USA

Approaches to Pharmaceutical Regulation in Europe and the USA. Panos Kanavos London School of Economics Washington, D.C., 10 June 2003. Agenda. Pharmaceutical Regulation in Europe Lessons for the US.

308 views • 30 slides

Medicines Pricing Policies in Europe

422 views • 26 slides

Parallel Trade in Scandinavia

Parallel Trade in Scandinavia. 14. The underlying process 15. The story 16. Example of a story 17 Price structures 18 Currencies 19 GBP 20 NOK 21 SEK 22 DKK 23 The next few years 24 Next century, the crystal ball 25 References 26 The end, the ecologial approach.

382 views • 26 slides

Pharmaceutical Reference Pricing in the U.S.

264 views • 26 slides

HTA Regulation and Economic Evaluation in Europe: where are we?

HTA Regulation and Economic Evaluation in Europe: where are we?. Professor Alistair McGuire, LSE, London Istanbul, May 2009. Outline. Introduction Background Some specific regulatory regimes and specific countries. Levels. Health expenditure growth versus GDP Growth.

416 views • 24 slides

Price control policy for patented medicines

Price control policy for patented medicines. Adun Mohara. Agenda Setting Model (Kingdon, 1984). PROBLEM STREAM. Window of opportunity. POLITICAL STREAM. POLICY STREAM. PROBLEM STREAM. Existence evident of problem Pharmaceutical high price in Thailand (Chaonsin, 2009)

357 views • 23 slides

Chapter Thirteen

Chapter Thirteen. Creating and Pricing Products That Satisfy Customers. 13 | 1. Learning Objectives. Explain what a product is and how products are classified Discuss the product life cycle and how it leads to new product development

395 views • 22 slides

How US Trade Policy Conflicts with Efforts by State Governments to Control Drug Costs

How US Trade Policy Conflicts with Efforts by State Governments to Control Drug Costs Mike Palmedo American Public Health Association November 5, 2007. Pfizer on Industry Influence.

316 views • 22 slides

Financing Global Health 2035 Sources of Revenue and Options for Cost Control

Financing Global Health 2035 Sources of Revenue and Options for Cost Control. Sanjeev Gupta Acting Director of Fiscal Affairs Department International Monetary Fund December 3, 2013 London. Presentation Outline. I. Incremental Costs. I. Incremental costs for convergence.

321 views • 20 slides

Choose the right reference-based pricing vendors to enjoy the optimum services!

The plan offered by the reference-based pricing vendors should include exception process and at the time the service should be considered to offer at the reference price. https://bit.ly/2Yl2dsW

35 views • 3 slides